All Articles

Review on gene and cell therapies in prostate cancer treatment: prospects and challenges

Risk factors influencing chronic inflammation in neoplastic transition to prostate cancer

The reactive stroma response regulates the immune landscape in prostate cancer

New approaches and prospects of immunotherapy and gene therapy for prostate cancer

Tumor-associated antigen targets for novel immune-based strategies in prostate cancer

Alternative isoforms of RNA polymerase III impact the non-coding RNA transcriptome, viability, proliferation and differentiation of prostate cancer cells

The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis

The effect of HMGB1 and RAGE on the clinicopathological and prognostic features of prostate cancer

Epigenetics in prostate cancer treatment

Genomic characterization of treatment-associated small cell neuroendocrine carcinoma of the prostate

The association between genetic variants in HSD3B1 and clinical management of PCa

Molecular insight: SERPINB3 and AR sensitivity might reduce the risk of COVID-19 infection and complications in prostate cancer patients receiving androgen-deprivation therapy

An update of aberrant methylation detection on circulating cell-free DNA as a tool to improve prostate cancer diagnosis and prognosis

Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases

Adenoid cystic carcinoma of the prostate: an unusual subtype of prostate cancer

Evolution of the prostate cancer genome towards resistance

The somatic clinico-genomics of localized, non-indolent prostate cancer